Serial measurements of lung function in a cohort of young children with bronchopulmonary dysplasia

Pediatrics

Volumn 125, Issue 6, 2010, Pages

  Fakhoury, Khoulood F ^a   Sellers, Charles ^a   Smith, E O'Brian ^a   Rama, Jennifer A ^a   Fan, Leland L ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Airway hyperresponsiveness; Bronchodilator response; Bronchopulmonary dysplasia; Forced deflation technique; Infant pulmonary function testing; Midexpiratory flows; Prematurity

Indexed keywords

BRONCHODILATING AGENT; STEROID; SURFACTANT;

ARTICLE; ARTIFICIAL VENTILATION; BIRTH WEIGHT; BODY PLETHYSMOGRAPHY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; EXPIRATORY FLOW; FEMALE; FUNCTIONAL RESIDUAL CAPACITY; GESTATIONAL AGE; HOSPITAL DISCHARGE; HUMAN; INFANT; LONGITUDINAL STUDY; LOW BIRTH WEIGHT; LUNG DYSPLASIA; LUNG FUNCTION; LUNG FUNCTION TEST; MALE; MAXIMAL EXPIRATORY FLOW; NEWBORN INTENSIVE CARE; OUTCOME ASSESSMENT; PREMATURITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE PAYMENT; SCORING SYSTEM; SYMPTOM; TREATMENT RESPONSE;

BRONCHOPULMONARY DYSPLASIA; CROSS-SECTIONAL STUDIES; FEMALE; FUNCTIONAL RESIDUAL CAPACITY; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LINEAR MODELS; LUNG; MALE; PLETHYSMOGRAPHY; PROSPECTIVE STUDIES; PULMONARY VENTILATION; RESPIRATORY FUNCTION TESTS;

EID: 77953049801     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2009-0668     Document Type: Article

References (25)

1. AdamsJMJr, Stark AR. Pathogenesis and clinical features of bronchopulmonary dysplasia. Available at: www.uptodateonline.com/patients/ content/topic.do?topicKey=~HYqeNRpTzP2T42Y&view=text. Accessed May 20, 2009
2. Baraldi E, Filippone M. Chronic lung disease after premature birth. N Engl J Med. 2007;357(19):1946
3. Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease: bronchopulmonary dysplasia. N Engl J Med. 1967;276(7):357-368
4. Rojas M, Gonzalez A, Bancalari E, et al. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr. 1995;126(4):605-610
5. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163(7):1723-1729
6. Coalson JJ, Winter VT, Siler-Khodr T, et al. Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med. 1999;160(4):1333-1346
7. Husain AN, Siddiqui NH, Stocker JT. Pathology of arrested acinar development in post surfactant bronchopulmonary dysplasia. Hum Pathol. 1998;29(7):710
8. Marshall DD, Kotelchuck M, Young TE, et al. Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. Pediatrics. 1999;104(6):1345-1350
9. Shennan AT, Dunn MS, Ohlsson A, et al. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics. 1988;82(4):527-532
10. Thurlbeck WM. Postnatal human lung growth. Thorax. 1982;37(8):564-571
11. Taussig LM. Maximal expiratory flows at functional residual capacity: a test of lung function for young children. Am Rev Respir Dis. 1977;116(6):1031-1038
12. Tepper RS, Reister T. Forced expiratory flows and lung volumes in normal infants. Pediatr Pulmonol. 1993;15(6):357-361
13. Tepper RS, Montgomery GL, Ackerman V, et al. Longitudinal evaluation of pulmonary function in infants and very young children with cystic fibrosis. Pediatr Pulmonol. 1993;16(2):96-100
14. Tepper RS, Morgan WJ, Cota K, et al. Expiratory flow limitation in infants with broncho-pulmonary dysplasia. J Pediatr. 1986;109(6):1040-1046
15. Mallory GB Jr, Chaney H, Mutich RL, et al. Longitudinal changes in lung function during the first three years of premature infants with moderate to severe bronchopulmonary dysplasia. Pediatr Pulmonol. 1991;11(1):8-14
16. Gerhardt T, Hehre D, Feller R, Reifenberg L, Bancalari E. Serial determination of pulmonary function in infants with chronic lung disease. J Pediatr. 1987;110(3):448-456
17. Baraldi E, Filippone M, Trevisanuto D, Zanardo V, Zacchello F. Pulmonary function until two years of life in infants with bronchopulmonary dysplasia. Am J Respir Crit Care Med. 1997;155(1):149-155
18. Farstad T, Brockmeier F, Bratlid D. Cardiopulmonary function in premature infants with bronchopulmonary dysplasia: a 2-year follow up. Eur J Pediatr. 1995;154(10):853-858
19. Robin B, Kim YJ, Huth J, et al. Pulmonary function in bronchopulmonary dysplasia. Pediatr Pulmonol. 2004;37(3):236-242
20. max(FRC) in infancy. Am J Respir Crit Care Med. 2002;165(8):1084-1092
21. Hiatt P, Eigen H, YuP, et al. Bronchodilator responsiveness in infants and young children with cystic fibrosis. Am Rev Respir Dis. 1988;137(1):119-122
22. Jobe AJ, Bancalari E. NICHD/NHLBI/ORD workshop summary. Am J Respir Crit Care Med. 2001;163(7):1723-1729
23. Halvorsen T, Skadberg BT, Eide GE, et al. Better care of immature infants: has it influenced long-term pulmonary outcome? Acta Paediatr. 2006;95(5):547-554
24. Kennedy JD, Edward LJ, Bates DJ, et al. Effects of birthweight and oxygen supplementation on lung function in late childhood in children of very low birth weight. Pediatr Pulmonol. 2000;30(1):32-40
25. Broughton S, Bhat R, Roberts A, et al. Diminished lung function, RSV and respiratory morbidity in prematurely born infants. Arch Dis Child. 2006;91(1):26-30